Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 239 followers
Latest posts
Last updated 3 days ago
Human medicines European public assessment report (EPAR): Idelvion, albutrepenonacog alfa, Date of authorisation: 11/05/2016, Revision: 13, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Idelvion, albutrepenonacog alfa, Date of...
Human medicines European public assessment report (EPAR): Axitinib Accord, axitinib, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Axitinib Accord, axitinib, Date of...
Human medicines European public assessment report (EPAR): Carbaglu, carglumic acid, Date of authorisation: 24/01/2003, Revision: 20, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Carbaglu, carglumic acid, Date of...
Human medicines European public assessment report (EPAR): Vocabria, cabotegravir, Date of authorisation: 17/12/2020, Revision: 11, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Vocabria, cabotegravir, Date of authorisation...
Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 7, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Epixram, levetiracetam, Status: Withdrawn application (before opinion)
3 days ago
Human medicines European public assessment report (EPAR): Epixram, levetiracetam, Status: Withdrawn application...
Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine, Date of authorisation: 11/12/2009, Revision: 17, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine...
Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of authorisation: 11/12/2009, Revision: 17, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of...
Human medicines European public assessment report (EPAR): Vanflyta, quizartinib, Date of authorisation: 06/11/2023, Revision: 3, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Vanflyta, quizartinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Simulect, basiliximab, Date of authorisation: 09/10/1998, Revision: 29, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Simulect, basiliximab, Date of authorisation...
Human medicines European public assessment report (EPAR): Travatan, travoprost, Date of authorisation: 27/11/2001, Revision: 31, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Travatan, travoprost, Date of authorisation...
Human medicines European public assessment report (EPAR): Sevelamer carbonate Winthrop (previously Sevelamer carbonate Zentiva), sevelamer carbonate, Date of authorisation: 15/01/2015, Revision: 23, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Sevelamer carbonate Winthrop (previously Sevelamer...